OBJECTIVETo examine whether the 1-h blood glucose measurement would be a more suitable screening tool for assessing the risk of diabetes and its complications than the 2-h measurement.
RESEARCH DESIGN AND METHODSWe conducted a prospective population-based cohort study of 4,867 men, randomly selected from prespecified birth cohorts between 1921 and 1949, who underwent an oral glucose tolerance test with blood glucose measurements at 0, 1, and 2 h. Subjects were followed for up to 39 years, with registry-based recording of events. Discriminative abilities of elevated 1-h ( ‡8.6 mmol/L) versus 2-h ( ‡7.8 mmol/L) glucose for predicting incident type 2 diabetes, vascular complications, and mortality were compared using Kaplan-Meier analysis, Cox proportional hazards regression, and net reclassification improvement. ), 636 (13%) developed type 2 diabetes. Elevated 1-h glucose was associated with incident diabetes (hazard ratio 3.40 [95% CI 2.90-3.98], P < 0.001) and provided better risk assessment than impaired glucose tolerance (Harrell concordance index 0.637 vs. 0.511, P < 0.001). Addition of a 1-h measurement in subjects stratified by fasting glucose provided greater net reclassification improvement than the addition of a 2-h measurement (0.214 vs. 0.016, respectively). Finally, the 1-h glucose was significantly associated with vascular complications and mortality.
RESULTS
Median age was 48 years (interquartile range [IQR] 48-49). During follow-up (median 33 years
CONCLUSIONSThe 1-h blood glucose level is a stronger predictor of future type 2 diabetes than the 2-h level and is associated with diabetes complications and mortality.Type 2 diabetes is associated with significant morbidity and mortality and represents a major burden on health care systems worldwide (1,2). Several randomized clinical trials provide evidence that type 2 diabetes can be prevented or at least postponed with lifestyle modification and drug therapy, which makes identifying high-risk individuals particularly important (3-6). Traditionally, prediabetes has been defined as impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) during a 2-h oral glucose tolerance test (OGTT), and interventional studies thus far have predominantly included subjects with IGT (7,8). However, not all subjects with prediabetes develop type 2